Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
RiverVest
AddedFeb 13, 2024
UpdatedJun 28, 2026
RiverVest

RiverVest

Operating

RiverVest Venture Partners®: A venture capital firm shaping early-stage life science companies for shareholder value.

Location
St. Louis, MO, US
Founded
2000
Firm
Compare
Portfolio
Employees
Website

RiverVest Venture Partners focuses on early-stage life science companies, leveraging extensive operating expertise to shape and create significant shareholder value. The firm primarily invests in Series A and B rounds, with a strong presence in Series C and later stages. RiverVest's investment strategy centers on identifying promising opportunities in the biotechnology and medical device sectors.

Notable portfolio companies include Mirum Pharmaceuticals, Wugen, and Spruce Biosciences. RiverVest's approach combines scientific insight, strategic guidance, and innovative thinking to support entrepreneurs in improving patients' lives. The firm offers value-add services to portfolio companies, utilizing its deep industry knowledge and connections to help startups navigate the complex life sciences landscape.

RiverVest - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments37
Current Portfolio Count21
Total Portfolio Exits2

Top Investment Stages

Series A12 (35.3%)
Series B11 (32.4%)
Series C5 (14.7%)
Series Unknown4 (11.8%)
Convertible Note2 (5.9%)

Stage Mix

Series A 35%Series B 32%Series C 15%Series Unknown 12%Convertible Note 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Avalyn Pharma logo

Avalyn Pharma

OncoResponse logo

OncoResponse

Spruce Biosciences logo

Spruce Biosciences

Venture Med Group logo

Venture Med Group

Bonum Therapeutics logo

Bonum Therapeutics

Bluejay Therapeutics logo

Bluejay Therapeutics

Biolinq logo

Biolinq

Wugen logo

Wugen

Glycomine logo

Glycomine

Sparrow Pharmaceuticals logo

Sparrow Pharmaceuticals

Arch Oncology logo

Arch Oncology

SeQure Dx logo

SeQure Dx

InterVene logo

InterVene

Mirum Pharmaceuticals logo

Mirum Pharmaceuticals

Neuros Medical logo

Neuros Medical

Genoa Pharmaceuticals logo

Genoa Pharmaceuticals

Adarza BioSystems logo

Adarza BioSystems

Lyric Pharmaceuticals logo

Lyric Pharmaceuticals

Tryton Medical logo

Tryton Medical

MacroGenics logo

MacroGenics

Kereos logo

Kereos

Auxeris Therapeutics logo

Auxeris Therapeutics

NexRay logo

NexRay

RiverVest - Similar Investment Firms

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Reservoir Venture Partners logo

Reservoir Venture Partners

Vestigo Ventures logo

Vestigo Ventures

Red Tree Venture Capital. logo

Red Tree Venture Capital.

R3 Venture Partners logo

R3 Venture Partners

Finistere Ventures logo

Finistere Ventures

finistere.com

Vertex Ventures HC logo

Vertex Ventures HC

Spring Mill Venture Partners logo

Spring Mill Venture Partners

Advent Venture Partners logo

Advent Venture Partners

Two Sigma Ventures logo

Two Sigma Ventures

Triangle Peak Partners logo

Triangle Peak Partners

Propel Venture Partners logo

Propel Venture Partners

propel.vc

Penguin Holdings logo

Penguin Holdings

Precursor Ventures logo

Precursor Ventures

precursorvc.com

Rose Ventures logo

Rose Ventures

roseventures.net

RiverVest - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end